株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

モノクローナル抗体薬の世界市場:市場規模、市場シェア、見通し、市場機会の分析 2018年~2026年

Monoclonal Antibody Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

発行 Coherent Market Insights 商品コード 785792
出版日 ページ情報 英文 187 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
モノクローナル抗体薬の世界市場:市場規模、市場シェア、見通し、市場機会の分析 2018年~2026年 Monoclonal Antibody Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
出版日: 2019年01月17日 ページ情報: 英文 187 Pages
概要

世界のモノクローナル抗体薬市場は、新薬の研究開発活動の活発化や、承認/上市される新薬の増加によって成長が促進されています。現在、多くのモノクローナル抗体がパイプラインとして研究開発されており予測期間に承認される見通しです。また、製薬企業によるモノクローナル抗体薬の適応症の拡大への努力も市場の成長を促すとされています。

当レポートでは、世界のモノクローナル抗体薬市場を調査し、市場の概要、種類・治療用途・流通チャネル・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 仮定
  • 略語

第2章 市場範囲

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場スニペット:種類別
    • 市場スニペット:治療用途別
    • 市場スニペット:流通チャネル別
    • 市場スニペット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、市場動向の分析

  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
    • 影響分析
  • 技術の進化
  • PEST分析
  • パイプライン分析
  • ファイブフォース分析

第4章 世界のモノクローナル抗体薬市場:種類別

  • イントロダクション
  • ヒト抗体
  • ヒト化抗体
  • キメラ抗体
  • その他

第5章 世界のモノクローナル抗体薬市場:治療用途別

  • イントロダクション
  • 腫瘍
  • 自己免疫疾患
  • 感染症
  • 血液疾患
  • その他

第6章 世界のモノクローナル抗体薬市場:流通チャネル別

  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • 専門薬局

第7章 世界のモノクローナル抗体薬市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • アフリカ
  • 中東

第8章 競争環境

  • 企業プロファイル
    • Pfizer, Inc.
    • Novartis International AG
    • Amgen, Inc.
    • Sanofi S.A.
    • Merck & Co., Inc.
    • GlaxoSmithKline Plc
    • F. Hoffman-La Roche Ltd.
    • AbbVie, Inc.
    • Eily, Lilly, and Company
    • Bristol-Myers Squibb Company

第9章 セクション

  • 参考文献
  • 調査方法
  • Coherent Market Insightsについて
目次

Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017, the U.S. Food & Drug Administration (FDA) approved Darzalex (daratumumab) in combination with pomalidomide and dexamethasone for the treatment of patients suffering from multiple myeloma, who have received two prior therapies. These factors are expected to support growth of the market over the forecast period.

Market Dynamics

Monoclonal antibody therapeutics market is driven by active research and development of novel drugs and significant number of new drug launches and approval. There are number of monoclonal antibodies in the pipeline, which are expected to receive approval over the forecast period. For instance, manufacturers such as Amgen, Inc., Novartis International AG, Merck & Co., Inc., Eily, Lilly, and Company, and others have several monoclonal antibodies in the pipeline. Moreover, efforts of manufacturers to increase number of indications (oncology) for monoclonal antibodies is further expected to boost the market growth over the forecast period. For instance, in June 2018, the U.S. Food & Drug Administration (FDA), expanded the indication of pembrolizumab (Keytruda) to include recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.

Key features of the study:

  • This report provides in-depth analysis of monoclonal antibody therapeutics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018-2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global monoclonal antibody therapeutics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
  • Key companies covered as a part of this study include Pfizer, Inc., Novartis International AG, Amgen, Inc., Sanofi S.A., Merck & Co., Inc., GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., AbbVie, Inc., Eily, Lilly, and Company, and Bristol-Myers Squibb Company
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, by technology up-gradation, market expansion, and marketing tactics
  • The global monoclonal antibody therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the monoclonal antibody therapeutics market

Detailed Segmentation:

  • Global Monoclonal Antibody Therapeutics Market, By Source:
    • Human
    • Humanized
    • Chimeric
    • Others
  • Global Monoclonal Antibody Therapeutics Market, By Therapeutic Application:
    • Oncology
    • Autoimmune Diseases
    • Infectious Diseases
    • Hematological Disorders
    • Others
  • Global Monoclonal Antibody Therapeutics Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Specialty Pharmacies
  • Global Monoclonal Antibody Therapeutics Market, By Geography:
    • North America
      • By Source:
      • Human
      • Humanized
      • Chimeric
      • Others
      • By Therapeutic Application:
      • Oncology
      • Autoimmune Diseases
      • Infectious Diseases
      • Hematological Disorders
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Specialty Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Europe
      • By Source:
      • Human
      • Humanized
      • Chimeric
      • Others
      • By Therapeutic Application:
      • Oncology
      • Autoimmune Diseases
      • Infectious Diseases
      • Hematological Disorders
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Specialty Pharmacies
      • By Country:
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Source:
      • Human
      • Humanized
      • Chimeric
      • Others
      • By Therapeutic Application:
      • Oncology
      • Autoimmune Diseases
      • Infectious Diseases
      • Hematological Disorders
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Specialty Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • By Source:
      • Human
      • Humanized
      • Chimeric
      • Others
      • By Therapeutic Application:
      • Oncology
      • Autoimmune Diseases
      • Infectious Diseases
      • Hematological Disorders
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Specialty Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East
      • By Source:
      • Human
      • Humanized
      • Chimeric
      • Others
      • By Therapeutic Application:
      • Oncology
      • Autoimmune Diseases
      • Infectious Diseases
      • Hematological Disorders
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Specialty Pharmacies
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Source:
      • Human
      • Humanized
      • Chimeric
      • Others
      • By Therapeutic Application:
      • Oncology
      • Autoimmune Diseases
      • Infectious Diseases
      • Hematological Disorders
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Specialty Pharmacies
      • By Country:
      • Central Africa
      • South Africa
      • North Africa
  • Company Profiles
    • Pfizer, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Novartis International AG
    • Amgen, Inc.
    • Sanofi S.A.
    • Merck & Co., Inc.
    • GlaxoSmithKline Plc
    • F. Hoffman-La Roche Ltd.
    • AbbVie, Inc.
    • Eily, Lilly, and Company
    • Bristol-Myers Squibb Company
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Source
    • Market Snippet, By Therapeutic Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
  • Technological Evolution
  • PEST Analysis
  • Pipeline Analysis
  • Porter's Analysis

4. Global Monoclonal Antibody Therapeutics Market, By Source, 2018-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Human
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)
  • Humanized
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)
  • Chimeric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)

5. Global Monoclonal Antibody Therapeutics Market, By Therapeutic Application, 2018-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)
  • Autoimmune Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)
  • Hematological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)

6. Global Monoclonal Antibody Therapeutics Market, By Distribution Channel, 2018-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)
  • Specialty Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2026, (US$ Mn)

7. Global Monoclonal Antibody Therapeutics Market, By Regions, 2018-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2026
  • North America
    • Market Size and Forecast, By Source, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Therapeutic Application, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2018-2026 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Source, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Therapeutic Application, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2018-2026 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Source, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Therapeutic Application, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2018-2026 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Source, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Therapeutic Application, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2018-2026 (US$ Mn)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Source, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Therapeutic Application, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2018-2026 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Source, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Therapeutic Application, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2018-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2018-2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Company Profiles
    • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Novartis International AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Amgen, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Sanofi S.A.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • GlaxoSmithKline Plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • F. Hoffman-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • AbbVie, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Eily, Lilly, and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bristol-Myers Squibb Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top